Microbial and Antibiotic Susceptibility Profile among Clinical Samples of Patients with Acute Leukemia

Introduction: Preventing and starting early treatment of infections in patients whose immunity system is weak due to malignancies like leukemia can reduce mortality. This study aimed to determine microbial and antibiotic resistance patterns in clinical samples of patients with acute leukemia to start early treatment before the results of clinical tests are known. Subjects and Methods: In this cross-sectional study, the clinical samples of all patients hospitalized with the diagnosis of acute leukemia were cultured and their antibiogram was evaluated. Then, the data were analyzed by SPSS 18 based on the objectives of the study. Results: Of a total of 2,366 samples, 18.95% were reported to be positive blood samples, 22.96% were reported to be urine samples and 36% wound samples. E. coli was the most common bacteria isolated from the blood and urine cultures (34% in blood, 32% in urine culture) while Staphylococcus Aureus was the most common in the wound culture (35%). The highest level of sensitivity in the organisms with positive blood culture was to Ciprofloxacin, while in positive urine and wound culture was to Imipenem. The highest resistance in blood, urine and wound culture was to Cotrimoxazole. Conclusion: According to results obtained from this study, it is necessary to conduct appropriate studies on this issue in specific conditions in our country. The findings of this study can be used in clinics for more accurate diagnosis, more effective treatment before the results of clinical tests are known and also for prevention of infection in cancer patients.

[1]  M. Alvarez,et al.  Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy , 2014, Haematologica.

[2]  Chunfu Li,et al.  Prophylactic First-Line Antibiotics Reduce Infectious Fever and Shorten Hospital Stay during Chemotherapy-Induced Agranulocytosis in Childhood Acute Myeloid Leukemia , 2014, Acta Haematologica.

[3]  J. Pérez-Simón,et al.  Patterns of infection in patients with myelodysplastic syndromes and acute myeloid leukemia receiving azacitidine as salvage therapy. Implications for primary antifungal prophylaxis. , 2014, Clinical lymphoma, myeloma & leukemia.

[4]  A. Ahmadzadeh,et al.  Infection Pattern of Neutropenic Patients in Post-chemotherapy Phase of Acute Leukemia Treatment , 2013, Hematology reports.

[5]  N. Mushtaq,et al.  Childhood acute lymphoblastic leukaemia: experience from a single tertiary care facility of Pakistan. , 2013, JPMA. The Journal of the Pakistan Medical Association.

[6]  P. Agarwal,et al.  T-lineage acute lymphoblastic leukemia and parvovirus infection in a child with neurofibromastosis-1. , 2013, Indian journal of pathology & microbiology.

[7]  E. Atenafu,et al.  Ambulatory consolidation chemotherapy for acute myeloid leukemia with antibacterial prophylaxis is associated with frequent bacteremia and the emergence of fluoroquinolone resistant E. Coli , 2013, BMC Infectious Diseases.

[8]  R. Marwaha,et al.  Severe Systemic Infection Masking Underlying Childhood Leukemia , 2013, Indian Journal of Hematology and Blood Transfusion.

[9]  K. Prabhash,et al.  Blood stream infections in cancer patients: a single center experience of isolates and sensitivity pattern. , 2010, Indian journal of cancer.

[10]  F. Marty,et al.  Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis. , 2010, Clinical therapeutics.

[11]  H. Goossens,et al.  Antibiotic Management of Febrile Neutropenia: Current Developments and Future Directions , 2010, Journal of chemotherapy.

[12]  M. Rahman,et al.  Levofloxacin prophylaxis to prevent bacterial infection in chemotherapy-induced neutropenia in acute leukemia. , 2010, Bangladesh Medical Research Council bulletin.

[13]  P. Hsueh,et al.  Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia , 2009, Epidemiology and Infection.

[14]  M. Saleem,et al.  Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan. , 2009, Indian journal of medical microbiology.

[15]  B. RicardoRabagliati,et al.  Invasive fungal disease in hemato-oncological and hematopoietic stem cell transplantation patients from Hospital Clinico Universidad Católica, Santiago-Chile using revised EORTC/MSG diagnostic criteria , 2009 .

[16]  M. Villegas,et al.  Identifying and controlling a multiresistant Pseudomonas aeruginosa outbreak in a Latin-American cancer centre and its associated risk factors. , 2009, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[17]  R. Hasan,et al.  Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: A descriptive study , 2008, BMC infectious diseases.

[18]  T. Qin,et al.  [Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia]. , 2007, Zhonghua yi xue za zhi.

[19]  M Koldehoff,et al.  Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients. , 2004, International journal of antimicrobial agents.

[20]  H. Kantarjian,et al.  Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  P. Varaldo,et al.  Recovery from a Single Blood Culture of Two Enterococcus gallinarum Isolates Carrying Both vanC-1 and vanA Cluster Genes and Differing in Glycopeptide Susceptibility , 2001, European Journal of Clinical Microbiology and Infectious Diseases.

[22]  I. Raad,et al.  Blood Products: A Significant Risk Factor for Long-Term Catheter-Related Bloodstream Infections in Cancer Patients , 2001, Infection Control & Hospital Epidemiology.

[23]  M. Salavert,et al.  [Bacteremia caused by Stenotrophomonas maltophilia: a clinical-epidemiological study and resistance profile]. , 1998, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.